AzTrials
AzTrials

Angle Class II, Division 1 MalocclusionNCT04743700

"Effects of Piezocision vs Micro-osteoperforations on the Rate of Maxillary Canine Retraction

A study testing Piezocision and Micro-osteoperforations in people with Angle Class II, Division 1 Malocclusion, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Acceleration of orthodontic tooth movement persuades tremendous rise in the interest of adolescents and aduts, as it not only shortens the treatment duration but also lessens the incidence of white spot lesions, root resorption, periodontal and other soft tissue problems. Read more about this study

Who is it for?
Ages 16 to 25 years
Conditions the study is for
Angle Class II, Division 1 Malocclusion
What is being tested?
Piezocision and Micro-osteoperforations
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteIndia
Study dates
25 Dec 2020to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patients with age between 16-25 years
  • Patients with Angle's class II division 1 malocclusion requiring bilateral extraction of maxillary first premolars.
  • Overjet of ≤ 10mm
  • No debilitating systemic disease.
  • No radiographic evidence of bone loss.
  • No history of periodontal disease/ therapy.
  • No smoking habit.
  • Probing depth of not more than 3mm in all teeth.

Who cannot join

  • Presence of any signs and symptoms of gingival and periodontal diseases.
  • Overjet more than 10mm.
  • Long-term drug history.
  • Systemic diseases.
  • Evidence of bone loss.
  • Smoking habit.

Trial locations and contacts

1 site in 1 country.

Manisha Kamal Kukreja, MDS contact

9215650617

mk3pgids@gmail.com

India1 site, 1 recruiting
  • Post Graduate Institute of Dental Sciences

    Rohtak, Haryana, 124001

    Recruiting

Other trials in India

About this study

Official title: "Effects of Piezocision vs Micro-osteoperforations on the Rate of Maxillary Canine Retraction: A Split Mouth Randomized Clinical Trial"

Acceleration of orthodontic tooth movement persuades tremendous rise in the interest of adolescents and aduts, as it not only shortens the treatment duration but also lessens the incidence of white spot lesions, root resorption, periodontal and other soft tissue problems. Minimal invasive techniques i.e.both piezocision and micro-osteoperforations had promising results in accelerating tooth movement. Therefore current study will provide evidence for better minimal invasive technique in terms of reducing treatment time and patient comfort.

Read the detailed description

Patients with Angle's Class II division 1 malocclusion meeting selection criteria and are indicated for maxillary first premolar extraction, patients will be referred for extraction of the maxillary first premolars , treatment will be initiated by bonding preadjusted MBT 0.022" slot straight wire appliance(Patient will be instructed to report immediately in case of breakage of appliance), after that, leveling and alignment will be done in all subjects, after insertion of 0.019"× 0.025" stainless steel arch wire, alginate impression and periapical radiograph of canine and first molar region will be taken(Before the initiation of canine retraction), randomisation and allocation of two sides of maxillary arch i.e. right and left will be done and active interventions(piezocision and micro-osteoperforations) for each side will be done, immediately maxillary canine retraction will be started with mini-implant and closed NiTi coil spring, patient will be asked to fill pain and discomfort assessment card immediately after initiation of canine retraction., subsequent impressions records will be taken at 4th, 8th, 12th and 16th weeks for measuring rate of maxillary canine retraction, data collection and interpretation of results, further pain assessment cards will be filled after 24 hours, on 7th day and 28th day

Being tested
Piezocision, Micro-osteoperforations
Medical subject headings
Malocclusion, Angle Class II

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PiezocisionProcedure or surgery

    Piezocisions with the help of piezotome , mesial and distal to a canine (in a vertical line) with the help of piezotome. These piezocisions will be performed on the buccal cortical bone only, 2-3mm below the alveolar crest level, 2mm deep into the bone under local anaesthesia (2% lidocaine with 1:100,000 epinephrine) and with standard asepsis, and gingival overlying will be incised first with blade number 15 in a Bard Parker handle . The exact location of incision will be determined by transgingival probing mesial and distal to the canine to know the alveolar crest level and to this measurement 2-3 mm is added and then 5mm incision is given in gingiva and overlying mucoperiosteum in a vertical line apically to expose the underlying bone.

  • Micro-osteoperforationsProcedure or surgery

    Three MOPs mesial and three MOPs distal to canine(in a vertical line) with the help of minisrew implant driver (fig.2). These MOPs will be performed on the buccal cortical bone only, 2-3 mm below the alveolar crest level, 2mm deep into the bone under local anaesthesia (2% lidocaine with 1:100,000 epinephrine) and with standard asepsis, and no flap will be raised. The exact location of first MOP will be determined by transgingival probing mesial and distal to the canine to know the alveolar crest level and to this measurement 2-3 mm is added. The location of second MOP at 5mm apically in a vertical line and third MOP at 5 mm apically to second MOP

Study groups in NCT04743700
Study groupRoleWhat they receive
Piezocision on Experimental Side AExperimentalPiezocisions with the help of piezotome , mesial and distal to a canine (in a vertical line) with the help of piezotome to accelerate maxillary canine retraction
Receives: Procedure: Piezocision
Micro-osteoperforations on Experimental side BExperimentalThree MOPs with the help of mini-implant screw driver,mesial and distal to canine(in a vertical line) with the help of minisrew implant driver to accelrate maxillary canine retraction
Receives: Procedure: Micro-osteoperforations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper or acrylic plug method after beginning of maxillary canine retraction

    Measured: 4th week

  2. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper or acrylic plug method after beginning of maxillary canine retraction

    Measured: 8th week

  3. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper or acrylic plug method after beginning of maxillary canine retraction

    Measured: 12th week

  4. Measurement of rate of canine retraction

    Distal movement of maxillary canine is measured in mm with the help of electric digital caliper or acrylic plug method after beginning of maxillary canine retraction

    Measured: 16th week

Secondary outcomes (4)
  1. Assessment of pain/discomfort level

    The participants will be asked to assess their level of discomfort on the day of initiation of canine retraction with visual analog scale(VAS).

    Measured: at the beginning of canine retraction

  2. Assessment of pain/discomfort level

    The participants will be asked to assess their level of discomfort on the day of initiation of canine retraction with visual analog scale(VAS).

    Measured: 24 hours

  3. Assessment of pain/discomfort level

    The participants will be asked to assess their level of discomfort on the day of initiation of canine retraction with visual analog scale(VAS).

    Measured: 7th day

  4. Assessment of pain/discomfort level

    The participants will be asked to assess their level of discomfort on the day of initiation of canine retraction with visual analog scale(VAS).

    Measured: 28th day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2021
  2. Study start25 Dec 2020
  3. Primary completionSep 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04743700
Sponsor's protocol ID
Karan.mahendru
Status last verified
Feb 2021
First submitted
14 Dec 2020
Last updated
8 Feb 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Piezocision and Micro-osteoperforations in people with Angle Class II, Division 1 Malocclusion, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Manisha Kamal Kukreja, MDS (9215650617, mk3pgids@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of rate of canine retraction (time frame: 4th week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in